SCHEMBL18921920

SCHEMBL18921920

CPn1nc(C)c2cc(-c3cncc(N4CCc5ccccc54)n3)cnc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK1 Q13464 2/20 0.37
▸ SMN1; SMN2 Q16637 4/20 0.36
▸ HSD17B10 Q99714 3/20 0.35
▸ NPC1 O15118 4/20 0.35
▸ RAB9A P51151 4/20 0.35
▸ MAPT P10636 4/20 0.35
▸ HPGD P15428 3/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ RXFP1 Q9HBX9 2/20 0.35
▸ AKT1 P31749 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ LMNA P02545 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ PIM3 Q86V86 1/20 0.33
▸ EGFR P00533 2/20 0.32
▸ MKNK1 Q9BUB5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14887076 0.90 ROCK1 (0.38) ROCK1SMN1; SMN2HSD17B10NPC1RAB9A
SCHEMBL12965734 0.80 ROCK1 (0.39) ROCK1SMN1; SMN2HSD17B10NPC1RAB9A
SCHEMBL12965663 0.80 ALDH1A1 (0.40) SMN1; SMN2HSD17B10NPC1RAB9AMAPT
SCHEMBL12965687 0.77 PDPK1 (0.42) ROCK1SMN1; SMN2HSD17B10NPC1RAB9A
SCHEMBL12821667 0.72 CDK8 (0.45) ROCK1SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL14887160 0.70 PDE10A (0.40) POLB
SCHEMBL14887161 0.69 PIM2 (0.43) ROCK1PIM1PIM3POLB
SCHEMBL14887081 0.66 PIM2 (0.41) ROCK1AKT1PIK3CAPIM1PIM3
SCHEMBL14887074 0.65 PIM1 (0.42) ROCK1PIM1PIM3POLB
SCHEMBL12813957 0.65 ROCK1 (0.51) ROCK1SMN1; SMN2HSD17B10NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9962382-B2 Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors ARRIEN PHARMACEUTICALS LLC (US) 2018-05-08 — — US disclosed
US-9669028-B2 Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors ARRIEN PHARMACEUTICALS LLC (US) 2017-06-06 — — US disclosed
Send feedback